GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for rtx-II toxin-activating lysine- acyltransferase apxiic (P0A3I4)

Analyse AlphaFold monomer V2.0 prediction for rtx-II toxin-activating lysine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
P0A3I4
Type
protein
Length
160 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x5e17C80A3064A18cE97C3a90e5C69D9a222F548e
Molecule
Rtx-II toxin-activating lysine-acyltransferase apxiic
UniProt
P0A3I4
Pockets
1 · best druggability 0.56

Structure

1 distinct chain · 47% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARtx-II toxin-activating lysine-acyltransferase apxiicprotein16047% helix, 25% strandP0A3I4

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12500.560.7725empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.